Until not too long ago, scientists who acted unethically in clinical trials did not necessarily face swift justice. Some debarment cases had been pending for over a decade. Now, the US Food and Drug Administration (FDA) says that it is trying to streamline the process of preventing unethical researchers from conducting clinical trials.(Click here to continue reading)

Image by steakpinball via Flickr Creative Commons